Filing Flows › ClearPoint Neuro (CLPT) › How it makes money
How ClearPoint Neuro (CLPT) makes money
ClearPoint Neuro (CLPT) made $12.1M of revenue in the third quarter 2026 (Q3 2026), +26% from a year earlier. Product brought in $7.9M (65%); Capital Equipment and Software brought in $1.7M (14%); Capital Equipment and Software Systems and Software Products brought in $1.3M (10%).
Drawing the Sankey…
Revenue by segment, Q3 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Product | $7.9M | 65.3% | — | +19% |
| ↳ Service | $4.2M | 34.6% | — | +20% |
| ↳ Biologics and Drug Delivery Services and License Fees | $3.7M | 30.7% | — | +19% |
| Capital Equipment and Software | $1.7M | 14.4% | — | +68% |
| Capital Equipment and Software Systems and Software Products | $1.3M | 10.5% | — | +96% |
| Biologics and Drug Delivery Disposable Products | $1.2M | 9.8% | — | -8% |
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $12.1M | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $12.1M | +36% |
| Q2 2026 | $10.9M | +18% |
| Q1 2026 | $12.1M | +43% |
| Q4 2025 | $10.4M | +34% |
| Q3 2025 | $8.9M | +9% |
| Q2 2025 | $9.2M | +17% |
| Q1 2025 | $8.5M | +11% |
From ClearPoint Neuro's 10-Q filed Oct 28, 2026 (on EDGAR).
Questions
How does ClearPoint Neuro make money?
ClearPoint Neuro (CLPT) made $12.1M of revenue in the third quarter 2026 (Q3 2026), +26% from a year earlier. Product brought in $7.9M (65%); Capital Equipment and Software brought in $1.7M (14%); Capital Equipment and Software Systems and Software Products brought in $1.3M (10%).
What is ClearPoint Neuro's biggest business?
Product: $7.9M in the third quarter 2026, 65% of revenue, +19% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.